SIMON PARKINSON: Open Payments
NPI 1114990371 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,848 in 168 payments from 39 companies in 2025. Trend: 2023 $7,500 · 2024 $9,138 · 2025 $9,848
Food & beverage: $3,888Speaker / faculty: $3,764Travel & lodging: $2,107Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $4,485 |
| Ipsen Innovation | 6 | $2,438 |
| Axsome Therapeutics, Inc. | 11 | $437 |
| PFIZER INC. | 14 | $275 |
| JAZZ PHARMACEUTICALS INC. | 7 | $221 |
| Biogen, Inc. | 13 | $204 |
| Eisai Inc. | 7 | $176 |
| Ipsen Biopharmaceuticals, Inc | 5 | $149 |
| Alexion Pharmaceuticals, Inc. | 5 | $137 |
| UCB, Inc. | 4 | $116 |
Products named: UBRELVY, QULIPTA, Symbravo, NURTEC ODT, XYWAV, TYSABRI, BOTOX, Leqembi.
Industry payments across AZ — which companies pay providers there.
